Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide injection videos are widely searched by people preparing for their first dose — and for good reason. Watching the KwikPen technique on screen is genuinely useful. What those videos can't do is confirm whether tirzepatide is clinically right for you, or show you how to handle the questions that come up mid-treatment. This page explains what to look for in a demonstration, which details matter, and where to go when a video leaves a gap. Tirzepatide (sold in the UK as Mounjaro) is a prescription-only medicine that requires clinical assessment before it can be prescribed — so a YouTube clip, however clear, is the beginning of the process, not the end.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A reliable demonstration will walk through the full sequence: removing the pen from the fridge, letting it reach a comfortable temperature, checking the solution is clear and colourless, selecting the injection site and rotating away from the last one, pinching the skin correctly, placing the pen flat (not at an angle), pressing and holding until the click confirms the dose has been delivered, then disposing of the used pen in a sharps bin. That last step matters. Sharps must go in a proper container, not a kitchen bin.
Credible videos come from Eli Lilly (the manufacturer), the NHS, or registered pharmacies with clinical oversight. You can watch the Mounjaro video we host, which covers the technique to the standard a prescriber would expect, alongside the Mounjaro jab video for a closer look at the injection steps. One pattern worth knowing: videos posted without any mention of prescription requirements or clinical suitability are a flag. Tirzepatide is a Prescription-Only Medicine; anyone presenting it as freely purchasable is not operating within UK law.
What you will not see covered in even the best video is how to handle nausea after a dose increase, what to do if you inject late, or how site reactions differ from person to person. Those answers live in the Patient Information Leaflet, and with your prescriber, who is the right person to ask before you change anything. The NHS tirzepatide medicines page is a solid starting point for side-effect information once you have read your own leaflet.
Yes, in a practical sense. Injection anxiety is common, our prescribers hear about it most weeks. Watching the KwikPen mechanism before the first dose demystifies the click, the hold-time and the needle retraction, all of which can feel alarming if you are not expecting them. Familiarity with the sequence means you are less likely to pull away early or miss the completion click.
The technique details that tend to be underestimated in videos: the temperature of the pen (a cold injection straight from the fridge is more uncomfortable), the importance of rotating sites rather than repeatedly using the same spot, and the pinch, or lack of it, depending on the site and the pen guidance in your leaflet. Abdomen injections are often easiest for first-timers; thigh and upper arm are equally valid alternatives.
Tirzepatide's dual GIP and GLP-1 mechanism means the medicine works systemically once absorbed, not at the injection site itself. So technique matters for comfort and consistent absorption, not because one spot produces better weight-loss results than another. If you want more on how the medicine works, the broader Mounjaro treatment overview goes into the pharmacology in plain terms.
Social media is full of individual weight-loss videos attributed to tirzepatide. Some are genuine accounts; some are not. Neither category is a reliable guide to what you should expect. Weight loss on tirzepatide varies with dose, duration, starting weight and how consistently someone follows the dietary and activity guidance that accompanies any prescription.
The controlled trial data (from SURMOUNT-1, which randomised 2,539 adults over 72 weeks) reported average body-weight reductions of around 20–21% at the 15 mg dose. The head-to-head SURMOUNT-5 trial, published in the New England Journal of Medicine in 2025, showed tirzepatide producing greater average weight reduction than semaglutide 2.4 mg. These are population averages from tightly monitored studies, and NICE's appraisal of tirzepatide (TA1026) draws on exactly this data when recommending it within the NHS eligibility framework. Individual results, whether in a clinical trial or on someone's video channel, don't transfer directly to you.
The cost of treatment is a common follow-up question once people have watched enough videos to take tirzepatide seriously. If pricing is on your mind, the UK Mounjaro price comparison page explains what private prescriptions typically cost and what those figures usually do and don't include.
A video can prepare you for the physical steps. It cannot substitute for clinical assessment. In the UK, tirzepatide requires a prescription, and that prescription can only follow a consultation in which a qualified prescriber reviews your health, your medications and whether this treatment is appropriate for your situation.
Timing this is something people think about more than you might expect, payday, a Monday order to beat the working week, before a holiday. The mechanics are simpler than most people assume. At nume, a consultation submitted before midday on a working day is reviewed the same day by a GPhC-registered Independent Prescriber, a named clinician, not automated software. If approved as clinically suitable, the pen is dispatched the same day and delivered free the next working day by DPD, in plain packaging.
Before trusting any online pharmacy, it is worth verifying it on the GPhC register. Our registration number is 9012878, and the register is publicly searchable. Pens sold without a prescription or through social-media sellers carry serious risks, the MHRA has warned repeatedly about counterfeit tirzepatide pens circulating in the UK, some of which have contained entirely different substances. Our clinical team background and pharmacy credentials are there to be checked.
If you have questions before starting, our tirzepatide information pages and the faqs page cover the most common ones. When you are ready, the next step is a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.